Liu, Jingwen
Tan, Meiling
Huang, Shuiwen
Zhang, Jun
Mao, Lejiao
Chen, Chengzhi
Fu, Yueqiang
Jiang, Xuejun
Zou, Zhen https://orcid.org/0000-0002-1651-591X
Funding for this research was provided by:
National Natural Science Foundation of China (32371177)
the Western Institute of Digital-Intelligent Medicine grant (WDIM2025JBGS-SZJY012)
Article History
Received: 3 February 2026
Accepted: 25 May 2026
First Online: 2 June 2026
Declarations
Ethics approval and consent to participate: All animal experiments were performed in accordance with the NIH Guide for the Care and Use of Laboratory Animals and reported following the ARRIVE guidelines, and approved by the Animal Experimental Ethics Committee of Chongqing Medical University (Approval No.: IACUC-CQMU-2023-0088). The clinical study was performed at University-Town Hospital of Chongqing Medical University, Chongqing, China. The study protocol was reviewed and approved by the Institutional Review Board of University-Town Hospital of Chongqing Medical University (Approval No.: LL-202146). Written informed consent was obtained from all participants or their legal surrogates. All ARDS patients met the Berlin Definition of ARDS.
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.